| Literature DB >> 24734202 |
Gino J Vricella1, Zachary Klaassen2, Martha K Terris2, Rabii Madi3.
Abstract
Objectives. This research was conducted to describe a novel technique for performing robotic-assisted laparoscopic prostatectomy (RALP) using a retrograde approach that mimics the classic open surgical technique. Methods. From June 2009 to March 2011, we performed 18 nonconsecutive RALPs using a novel retrograde approach. Patients were initially selected with D'Amico low to intermediate risk disease. Pre-, intra-, and postoperative data were analyzed in all patients. Results. All 18 patients had successful surgery without any intraoperative complications. Mean preoperative PSA was 6.0 ng/mL. Nine patients had biopsy Gleason score (GS) 6, seven patients had GS 7, and two patients had GS 8. Fourteen patients had clinical stage T1c and four patients had stage T2a. Mean operative time was 198 minutes, with a mean robotic console time of 168 minutes. Fifteen patients had T2 disease on the final pathology and three had T3 disease. With a median follow-up of 11 months, 10 patients had an undetectable PSA. Conclusions. Our early experience with retrograde robotic-assisted laparoscopic prostatectomy demonstrates the feasibility of this approach with early outcomes comparable to the contemporary antegrade approach. Long-term study with a greater number of patients will be necessary to fully evaluate the oncologic and functional outcomes using this technique.Entities:
Year: 2014 PMID: 24734202 PMCID: PMC3964898 DOI: 10.1155/2014/945604
Source DB: PubMed Journal: ISRN Urol ISSN: 2090-5807
Figure 1The lateral prostatic fascia is dissected sharply from the base of the prostate to its apex.
Figure 2(a) With the NVB secured, the urethra is incised at the apex of the prostate, exposing the Foley catheter. (b) The posterior urethra is transected with subsequent retrograde dissection of the prostate off the rectum.
Figure 3The prostate is dissected in a retrograde fashion until the seminal vesicles and vas deferens are reached.
Preoperative, operative, and postoperative patient demographics and outcomes for 18 patients undergoing retrograde robotic-assisted laparoscopic prostatectomy.
| Patient and procedure variables | Outcome |
|---|---|
| Preoperative | |
| Mean age, years (range) | 59 (42–76) |
| Mean BMI, kg/m2 (range) | 28 (21–37) |
| Mean PSA, ng/mL (range) | 6.0 (1.2–23.0) |
| Mean IPSS (median) | 8 (8) |
| Mean SHIM (median) | 19 (23) |
| Biopsy Gleason score | 6 ( |
| 7 ( | |
| 8 ( | |
| Clinical T stage | T1c ( |
| T2a ( | |
| Operative | |
| Mean operative time, min (range) | 198 (150–300) |
| Mean robotic console time, min (range) | 168 (118–265) |
| Nerve-sparing procedure | Total ( |
| Partial ( | |
| None ( | |
| Bladder-neck sparing procedure | Yes ( |
| No ( | |
| Pelvic lymph node dissection | Yes ( |
| No ( | |
| Mean EBL, mL (range) | 142 (40–300) |
| Postoperative | |
| Final Gleason score | 6 ( |
| 7 ( | |
| 8 ( | |
| Multifocal cancer | Yes ( |
| No ( | |
| Margin status | Negative ( |
| Positive ( | |
| Location of positive margin | Bladder neck ( |
| Apex ( | |
| Lymph node invasion | Yes ( |
| No ( | |
| Unknown ( | |
| Pathologic T stage | T2a ( |
| T2c ( | |
| T3a ( | |
| T3b ( | |
| Mean hospital stay, days (range) | 2 (1–3) |
| Transfusions | None |
| 30-day complications |
|
BMI: Body Mass Index, PSA: Prostate Specific Antigen, IPSS: International Prostate Symptom Score, SHIM: Sexual Health Inventory for Men, and EBL: estimated blood loss.
*Both patients with deep-vein thrombosis.